Aug 03, 2026, 07:45 ETLilly's olomorasib receives U.S. FDA's Breakthrough Therapy designation for the treatment of...
INDIANAPOLIS, Aug. 3, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to...